Interview: The Importance of Nasal Modelling: An Interview with ONdrugDelivery

June 15, 2022

Nasal delivery is appealing to drug developers for various reasons. It is a relatively painless and easily accessible route of administration and- due to its rapid onset and direct access to the central nervous system (CNS)- is well-suited for emergency medications. Although delivery to the nasal cavity is more straightforward than some other delivery routes, it is not without challenges. Physical modelling can be a valuable tool for identifying and overcoming such challenges.

In this article with ONdrugDelivery, our Chief Scientific Officer, Dr. Jon Lenn, and Senior Director of Research Biology and Innovation, Dr. Jon Volmer, discuss the importance of nasal modelling and how MedPharm’s proprietary nasal cavity modelling technology, MedCast, can be used to refine and optimise nasal formulations.

Read the full article here.

Interested in learning more about MedPharm’s inhalation solutions? Schedule a meeting with our team today.

About MedPharm
MedPharm is the world’s leading contract provider of topical and transdermal formulation development and manufacturing services. Our experts specialize in reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through cost-effective and industry-leading performance testing models. Well-established as the global leader in dermal and transdermal product development, MedPharm also offers innovative solutions for airway, ophthalmic, otic, ungual, and other topical preparations. With locations in both the US and the UK, MedPharm is the CDMO of choice for developers around the globe.